Follow
Michael Walsh
Michael Walsh
Population Health Research Institute & McMaster University
Verified email at phri.ca
Title
Cited by
Cited by
Year
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis
RB Jones, JW Cohen Tervaert, T Hauser, R Luqmani, MD Morgan, ...
New England Journal of Medicine 363 (3), 211-220, 2010
19792010
Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension
M Walsh, PJ Devereaux, AX Garg, A Kurz, A Turan, RN Rodseth, ...
Anesthesiology 119 (3), 507-515, 2013
15022013
Discrimination and Calibration of Clinical Prediction Models: Users’ Guides to the Medical Literature
AC Alba, T Agoritsas, M Walsh, S Hanna, A Iorio, PJ Devereaux, ...
Jama 318 (14), 1377-1384, 2017
11412017
Long-term patient survival in ANCA-associated vasculitis
O Flossmann, A Berden, K de Groot, C Hagen, L Harper, C Heijl, ...
Annals of the rheumatic diseases 70 (3), 488-494, 2011
9772011
Myocardial Injury after Noncardiac Surgery: A Large, International, Prospective Cohort Study Establishing Diagnostic Criteria, Characteristics, Predictors, and 30-day Outcomes
F Botto, P Alonso-Coello, MTV Chan, JC Villar, D Xavier, S Srinathan, ...
Anesthesiology 120 (3), 564-578, 2014
9452014
Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial
BF Culleton, M Walsh, SW Klarenbach, G Mortis, N Scott-Douglas, ...
Jama 298 (11), 1291-1299, 2007
7932007
Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery
PJ Devereaux, BM Biccard, A Sigamani, D Xavier, MTV Chan, ...
Jama 317 (16), 1642-1651, 2017
7582017
Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody–associated vasculitis: A randomized controlled trial
TF Hiemstra, M Walsh, A Mahr, CO Savage, K De Groot, L Harper, ...
Jama 304 (21), 2381-2388, 2010
6522010
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
M Walsh, PA Merkel, CA Peh, WM Szpirt, X Puéchal, S Fujimoto, ...
New England Journal of Medicine 382 (7), 622-631, 2020
6392020
Avacopan for the treatment of ANCA-associated vasculitis
DRW Jayne, PA Merkel, TJ Schall, P Bekker
New England Journal of Medicine 384 (7), 599-609, 2021
6362021
The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index
M Walsh, SK Srinathan, DF McAuley, M Mrkobrada, O Levine, C Ribic, ...
Journal of clinical epidemiology 67 (6), 622-628, 2014
5712014
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta …
SC Palmer, B Tendal, RA Mustafa, PO Vandvik, S Li, Q Hao, D Tunnicliffe, ...
bmj 372, 2021
5282021
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up
L Harper, MD Morgan, M Walsh, P Hoglund, K Westman, O Flossmann, ...
Annals of the rheumatic diseases 71 (6), 955-960, 2012
5102012
Risk factors for relapse of antineutrophil cytoplasmic antibody–associated vasculitis
M Walsh, O Flossmann, A Berden, K Westman, P Höglund, C Stegeman, ...
Arthritis & Rheumatism 64 (2), 542-548, 2012
4002012
Risk factors for relapse of antineutrophil cytoplasmic antibody–associated vasculitis
M Walsh, O Flossmann, A Berden, K Westman, P Höglund, C Stegeman, ...
Arthritis & Rheumatism 64 (2), 542-548, 2012
4002012
Risk factors for relapse of antineutrophil cytoplasmic antibody–associated vasculitis
M Walsh, O Flossmann, A Berden, K Westman, P Höglund, C Stegeman, ...
Arthritis & Rheumatism 64 (2), 542-548, 2012
4002012
Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
CM Clase, JJ Carrero, DH Ellison, ME Grams, BR Hemmelgarn, ...
Kidney international 97 (1), 42-61, 2020
3682020
Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses
S Schandelmaier, M Briel, R Varadhan, CH Schmid, N Devasenapathy, ...
CMAJ 192 (32), E901-E906, 2020
3672020
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
AA House, C Wanner, MJ Sarnak, IL Piña, CW McIntyre, P Komenda, ...
Kidney international 95 (6), 1304-1317, 2019
3232019
The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis—a simulation study
K Thorlund, G Imberger, M Walsh, R Chu, C Gluud, J Wetterslev, G Guyatt, ...
PloS one 6 (10), e25491, 2011
3192011
The system can't perform the operation now. Try again later.
Articles 1–20